Annual Report 2022

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2022 139 The United Laboratories International Holdings Limited Annual Report 2022 38. FINANCIAL INSTRUMENTS (Continued) Financial risk management objectives and policies (Continued) Credit risk and impairment assessment (Continued) External Internal Gross credit credit 12m or carrying 2021 Notes rating rating lifetime ECL amount RMB’000 Pledged bank deposits 25 A1 to Ba1 N/A 12m ECL 827,389 Other pledged deposits 29 A2 to A3 N/A 12m ECL 24,000 Bank balances 25 Aa1 to Ba1 N/A 12m ECL 3,330,867 Other receivables and refundable deposits 24 N/A Note 1 12m ECL 125,431 Consideration receivables 24 N/A Note 4 Lifetime ECL (credit-impaired) 339,574 Banker’s acceptance bills receivables 24 A1 to B1 N/A 12m ECL 1,821,768 Trade receivables 24 N/A Note 2 Lifetime ECL (provision matrix) 1,624,198